Patent US4397844A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4397844A Expired / Lapsed US ⏱️ 0.0 years remaining

Antigen derivatives and processes for their preparation

Assignee: Novartis Corp
•
Filing: 1981-09-17
•
Granted: 1983-08-09
•
Expires: 2001-09-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to novel antigen derivatives comprising an antigen and at least one muramylpeptide covalently bonded thereto, if appropriate via a spacer, to pharmaceutical preparations which contain such compounds and to their use as a vaccine. The novel antigen derivatives produce a pronounced increase in the immuno-response to the antigen, and in particular also a cell-medicated immunity under clinically acceptable conditions of administration.

Inventors

  • 👤 Gerhard Baschang
  • 👤 Felix M. Dietrich
  • 👤 Roland Gisler
  • 👤 Albert Hartmann
  • 👤 Jaroslav Stanek
  • 👤 Lajos Tarcsay

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 04:08
CPC Classifications
C; C07; C07H; C07H9/00; C07H9/02; C07H9/04; A; A61; A61K; A61K39/00; A61K39/385; C07H23/00; C07K; C07K9/00; C07K9/001; C07K9/005; A61K2039/555; A61K2039/55511; A61K2039/55583; A61K2039/60; A61K2039/6031; A61K2039/6062; Y; Y02; Y02A; Y02A50/00; Y02A50/30; Y10; Y10S; Y10S530/00; Y10S530/806; Y10S530/807

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 378 words
A compound of the formula I ##STR10## in which X is a carbonyl group, R 1 , R 4 and R 6 independently of one another represent hydrogen tri-lower alkyl-silyl, alkyl having from 1 to 18 carbon atoms, benzyl which is unsubstituted or substituted in the aromatic nucleus by lower alkyl, hydroxyl, lower alkoxy, lower alkylenedioxy, mercapto, lower alkylmercapto, trifluoromethyl and/or halogen, or represent alkanoyl having from 2 to 18 carbon atoms, benzoyl or naphthoyl which are unsubstituted or substituted by halogen, lower alkyl, lower alkoxy, trifluoromethyl, hydroxyl or lower alkanoyloxy, or represent an acyl radical of a lower alkanesulfonic acid or of phenylsulfonic acid, which is unsubstituted or substituted by lower alkyl or halogen, or represent carbamoyl, lower alkyl-carbamoyl or phenyl-carbamoyl, R 2 represents alkyl having 1 to 18 carbon atoms which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, halogen, mercapto, lower alkylmercapto, lower alkanoylmercapto, carboxy, lower alkoxycarbonyl and/or carbamoyl, or represents phenyl which is unsubstituted or substituted by lower alkyl, hydroxy, lower alkoxy, lower alkanoyl, lower alkylenedioxy, halogen and/or trifluoromethyl, R 3 represent hydrogen or lower alkyl, at least one of the radicals R 7 , R 9 and R 13 represents lower alkyl, and the others represent hydrogen, R 8 is hydrogen, lower alkyl which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, mercapto, lower alkylmercapto, lower alkanoylmercapto, amino, lower alkanoylamino, carbamoylamino or cycloalkyl having 5 or 6 carbon atoms, or represents cycloalkyl-lower alkyl having 5 or 6 carbon atoms, in the cyclic moiety, phenyl or phenyl-lower alkyl, in which the phenyl radicals are unsubstituted or substituted as defined above, or heterocyclyl or heterocyclyl-lower alkyl wherein the heterocyclyl radicals are 5- or 6-membered, contain one or two nitrogen atoms in the ring and may or may not contain a fused phenyl radical, R 7 and R 8 together can also represent alkylene having 3 or 4 carbon atoms, R 10 , R 11 and R 12 independently of one another represent carboxyl, lower alkoxycarbonyl or carbamoyl which is unsubstituted or mono- or disubstituted at the nitrogen atom by unsubstituted, or carboxy- or carbamoyl-substituted, lower alkyl or by phenyl, benzyl, tetramethylene or pentamethylene or R 11 can also be hydrogen, or a salt of such a compound having a salt-forming group.
Claim 2
Dependent Claim 378 words
A compound of the formula I ##STR10## in which X is a carbonyl group, R 1 , R 4 and R 6 independently of one another represent hydrogen tri-lower alkyl-silyl, alkyl having from 1 to 18 carbon atoms, benzyl which is unsubstituted or substituted in the aromatic nucleus by lower alkyl, hydroxyl, lower alkoxy, lower alkylenedioxy, mercapto, lower alkylmercapto, trifluoromethyl and/or halogen, or represent alkanoyl having from 2 to 18 carbon atoms, benzoyl or naphthoyl which are unsubstituted or substituted by halogen, lower alkyl, lower alkoxy, trifluoromethyl, hydroxyl or lower alkanoyloxy, or represent an acyl radical of a lower alkanesulfonic acid or of phenylsulfonic acid, which is unsubstituted or substituted by lower alkyl or halogen, or represent carbamoyl, lower alkyl-carbamoyl or phenyl-carbamoyl, R 2 represents alkyl having 1 to 18 carbon atoms which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, halogen, mercapto, lower alkylmercapto, lower alkanoylmercapto, carboxy, lower alkoxycarbonyl and/or carbamoyl, or represents phenyl which is unsubstituted or substituted by lower alkyl, hydroxy, lower alkoxy, lower alkanoyl, lower alkylenedioxy, halogen and/or trifluoromethyl, R 3 represent hydrogen or lower alkyl, at least one of the radicals R 7 , R 9 and R 13 represents lower alkyl, and the others represent hydrogen, R 8 is hydrogen, lower alkyl which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, mercapto, lower alkylmercapto, lower alkanoylmercapto, amino, lower alkanoylamino, carbamoylamino or cycloalkyl having 5 or 6 carbon atoms, or represents cycloalkyl-lower alkyl having 5 or 6 carbon atoms, in the cyclic moiety, phenyl or phenyl-lower alkyl, in which the phenyl radicals are unsubstituted or substituted as defined above, or heterocyclyl or heterocyclyl-lower alkyl wherein the heterocyclyl radicals are 5- or 6-membered, contain one or two nitrogen atoms in the ring and may or may not contain a fused phenyl radical, R 7 and R 8 together can also represent alkylene having 3 or 4 carbon atoms, R 10 , R 11 and R 12 independently of one another represent carboxyl, lower alkoxycarbonyl or carbamoyl which is unsubstituted or mono- or disubstituted at the nitrogen atom by unsubstituted, or carboxy- or carbamoyl-substituted, lower alkyl or by phenyl, benzyl, tetramethylene or pentamethylene or R 11 can also be hydrogen, or a salt of such a compound having a salt-forming group.
Claim 3
Dependent Claim 30 words
Compounds of the formula I according to claim 1, in which at least one of the radicals R 7 , R 9 and R 13 represents methyl, and salts thereof.
Claim 4
Dependent Claim 71 words
Compounds of the formula I according to claim 1, in which R 1 , R 4 , R 6 , R 11 and R 13 represent hydrogen, R 2 represents methyl or phenyl, R 3 represents hydrogen or methyl, R 7 represents methyl, ethyl or propyl, R 8 represents hydrogen, methyl or ethyl, R 9 represents hydrogen or methyl, R 10 represents carbamoyl and R 12 represents carboxy, and salts thereof.
Claim 5
Dependent Claim 24 words
Compounds of the formula I according to claim 1, in which R 7 represents lower alkyl and R 13 represents hydrogen, and salts thereof.
Claim 6
Dependent Claim 18 words
Compounds of the formula I according to claim 4, in which R 3 represents methyl, and salts thereof.
Claim 7
Dependent Claim 9 words
N-acetyl-normuramyl-L-(N-methyl)-alanyl-D-isoglutamine .tbd.2-acetylamino-3-O-{[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-ethyl]-N-methyl-carbamoylmethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 8
Dependent Claim 9 words
N-benzoyl-normuramyl-L-(N-ethyl)-α-amino-butyryl-D-isoglutamine .tbd.2-benzoylamino-3-O-{[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-propyl]-N-ethyl-carbamoylmethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 9
Dependent Claim 9 words
N-acetyl-muramyl-L-(N-methyl)-α-aminobutyryl-D-isoglutamine .tbd.2-acetylamino-3-O-{D-1-[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-propyl]-N-methyl-carbamoyl-ethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 10
Dependent Claim 10 words
N-acetyl-muramyl-L-(N-ethyl)-alanyl-D-isoglutamine .tbd. 2-acetylamino-3-O-{D-1-[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-ethyl]-N-ethyl-carbamoyl-ethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 11
Dependent Claim 101 words
Compounds of the formula I according to claim 1 in which R 1 , R 4 and R 6 represent hydrogen, X represents carbonyl, R 2 represents lower alkyl which is unsubstituted or substituted by hydroxy or by methoxy, or phenyl which is unsubstituted or substituted by hydroxy, methoxy, methyl, ethyl or by halogen, R 3 and R 9 represent hydrogen or methyl, R 8 represents methyl, ethyl, n-propyl, isopropyl, 2-methylpropyl, methylmercaptomethyl, hydroxymethyl, hydroxyethyl, phenyl, benzyl or p-hydroxybenzyl, R 10 , R 11 and R 12 represent carboxy, lower alkoxycarbonyl or carbamoyl and R 11 also represents hydrogen, and salts thereof.
Claim 12
Dependent Claim 18 words
Compounds of the formula I according to claim 3, in which R 3 represents methyl, and salts thereof.
Claim 13
Dependent Claim 16 words
A compound according to claim 1, wherein R, R 4 , and R 6 are trimethylsilyl.
Claim 14
Dependent Claim 29 words
Pharmaceutical preparations for potentiating the immune-response of warm blooded animals, including man, containing an effective amount of a compound according to claim 1 together with a pharmaceutically acceptable carrier.
Claim 15
Dependent Claim 99 words
A pharmaceutical preparation according to claim 13, in which R 1 , R 4 and R 6 represent hydroen, X represents carbonyl, R 2 represents lower alkyl which is unsubstituted or substituted by hydroxy or by methoxy, or phenyl which is unsubstituted or substituted by hydroxy, methoxy, methyl, ethyl or by halogen, R 3 and R 9 represent hydrogen or methyl, R 8 represents methyl, ethyl, n-propyl, isopropyl, 2-methylpropyl, methylmercaptomethyl, hydroxymethyl, hydroxyethyl, phenyl, benzyl or p-hydroxybenzyl, R 10 , R 11 and R 12 represent carboxy, lower alkoxycarbonyl or carbamoyl and R 11 also represents hydrogen, and salts thereof.
Claim 16
Dependent Claim 69 words
A pharmaceutical preparation according to claim 13, in which R 1 , R 4 , R 6 , R 11 and R 13 represent hydrogen, R 2 represents methyl or phenyl, R 3 represents hydrogen or methyl, R 7 represents methyl, ethyl or propyl, R 8 represents hydrogen, methyl or ethyl, R 9 represents hydrogen, or methyl, R 10 represents carbamoyl and R 12 represents carboxy, and salts thereof.
Claim 17
Dependent Claim 19 words
A pharmaceutical preparation according to claim 13, in which R 7 is lower alkyl and R 13 is hydrogen.
Claim 18
Dependent Claim 16 words
A pharmaceutical preparation according to claim 15, in which R 3 is methyl, and salts thereof.
Claim 19
Dependent Claim 18 words
A compound according to claim 10, in which R 7 is lower alkyl and R 13 is hydrogen.
Claim 20
Dependent Claim 12 words
A compound according to claim 18, in which R 7 is methyl.
Claim 21
Dependent Claim 25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 1.
Claim 22
Dependent Claim 25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 10.
Claim 23
Dependent Claim 25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 4.
Claim 24
Dependent Claim 25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 18.
Claim 25
Dependent Claim 25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 19.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-08 1987-02-07 1987-08-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-08 1991-02-07 1991-08-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-08 1995-02-07 1995-08-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag